Discover Tenders by Sharps Containers Sector

Find the most relevant tenders for Sharps Containers. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Sharps Containers tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Sharps Containers tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Chlorthalidone Atc C03Ba04 Obg For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7189539

EMD:Ref Document

Bid Value: Ref Document

29 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Capsaicin Atc N01Bx04 Obg For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7186844

EMD:Ref Document

Bid Value: Ref Document

29 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Milnacipran Atc N06Ax17 Obg For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7175295

EMD:Ref Document

Bid Value: Ref Document

29 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Miglustat Atc Code According To Who A16Ax06

Deadline: 31 Aug 2026

Germany

Ref. No.: 7169020

EMD:Ref Document

Bid Value: Ref Document

86 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Natalizumab Exclusively In Dafo Injection Solution Atc L04Aa23 Obo For The Period 01 09 24 31 08 26

Deadline: 05 Jul 2026

Germany

Ref. No.: 7164900

EMD:Ref Document

Bid Value: Ref Document

29 Days Left

Open House Original Rebate Agreements 2024 06 Aclidinium Bromide Formoterol Active Ingredient Combination

Deadline: 31 Aug 2026

Germany

Ref. No.: 7154440

EMD:Ref Document

Bid Value: Ref Document

86 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Dexamethasone Atc Code H02Ab02 That Can Be Prescribed And Dispensed As Part Of The Consultation Hou

Deadline: 27 Jun 2026

Germany

Ref. No.: 7146194

EMD:Ref Document

Bid Value: Ref Document

21 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Propofol Atc Code N01Ax10 That Can Be Prescribed And Dispensed As Part Of The Outpatient Needs In L

Deadline: 27 Jun 2026

Germany

Ref. No.: 7145649

EMD:Ref Document

Bid Value: Ref Document

21 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Evolocumab C10Ax13 Within The Framework Of A So Called Open House Model

Deadline: 01 Jul 2026

Germany

Ref. No.: 7110598

EMD:Ref Document

Bid Value: Ref Document

25 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Lanthanum Iii Carbonate Chewable Tablets Only V03Ae03 Within The Framework Of A So

Deadline: 01 Jul 2026

Germany

Ref. No.: 7110380

EMD:Ref Document

Bid Value: Ref Document

25 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Rivaroxaban Atc B01Af01 In The Active Strength 2 5 Mg Per Divided Oral Dosage Form

Deadline: 27 Jun 2026

Germany

Ref. No.: 6914003

EMD:Ref Document

Bid Value: Ref Document

21 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Clobetasol Atc Code D07Ad01

Deadline: 27 Jun 2026

Germany

Ref. No.: 6880834

EMD:Ref Document

Bid Value: Ref Document

21 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Rivaroxaban Atc B01Af01 In All Strengths Except 2 5 Mg Per Divided Oral Dosage Form

Deadline: 27 Jun 2026

Germany

Ref. No.: 6879610

EMD:Ref Document

Bid Value: Ref Document

21 Days Left

Medicines Containing The Active Ingredient Alitretinoin Atc D11Ah04

Deadline: 30 Jun 2026

Germany

Ref. No.: 6852185

EMD:Ref Document

Bid Value: Ref Document

24 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Formoterol And Beclometasone Atc Code R03Ak08

Deadline: 27 Jun 2026

Germany

Ref. No.: 6850265

EMD:Ref Document

Bid Value: Ref Document

21 Days Left

Showing 20941 to 20955 of 21006 results

‹
1
2
...
1392
1393
1394
1395
1396
1397
1398
1399
1400
1401
›

Discover Tenders by Sharps Containers Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Sharps Containers Sector

Filter Your Search

FREE Trial plan for all new users!